Beth Israel Deaconess Medical Center;The General Hospital Corporation;Dana-Farber Cancer Institute, Inc.
发明人:
Wilson, Samuel B.,Balk, Steven P.,Exley, Mark A.
申请号：
DK10012392
公开号：
DK2336187T3
申请日:
2001.06.19
申请国别(地区):
DK
年份:
2016
代理人:
摘要：
The invention provides compounds and methods for the ex vivo or in vivo<； expansion of NK T cells, CD1d-reactive T cells, and J alpha Q<；+>； cells, and the modulation of their activities. These compounds and methods have diagnostic and therapeutic applications.
